AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a Fully Human Anti-TNFalpha Monoclonal Antibody
- Written by ACN Newswire - Press Releases
Read more //?#
.
Block's layoffs are a design win. Here's why
We spend millions designing features that save users 30 seconds. Block just saved thousands of employees 40 hours a week. That's not a crisis. That's...
Why I Decided to Build a Better Way to Build Homes
Why does building a home still feel like stepping into the unknown? In an industry where costs blow out and decisions come too late, certainty has...
Leonardo.Ai reveals new brand, expanding its creator-first platform for the next era of generative AI
The company has also launched its developer API to empower creators and builders to integrate AI into their workflows SYDNEY, Australia – 19 Febr...
Psychosocial injury risk starts inside workplace microcultures
Psychological injury is now one of the most expensive categories of workers compensation claims in Australia, with Safe Work Australia reporting t...
2025 Thryv Business and Consumer Report - Australian small businesses show grit under pressure
Australia’s small businesses are powering ahead with optimism, resilience and discipline, however, mounting pressures on costs, wellbeing and cons...
Security by Default: Why 2026 Will Force Organisations to Rethink Cloud and AI
financial accountability to how they run cloud and AI, according to leading Australian systems integrator, Brennan. Based on customer insights...